Abiopharma

🔍 Klimowich John (Executive)

Company: Columbia Financial, Inc. (CLBK)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 33 shares of Common Stock at $20.86 per share (Direct)
  Date: 2026-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,212.59 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | shares_owned_after: 63,662.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By 401(k) | shares_owned_after: 17,130.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 8,689.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By SERP | shares_owned_after: 7,627.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By SIM | shares_owned_after: 4,214.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By Stock Award III | shares_owned_after: 10,971.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By Stock Award IV | shares_owned_after: 11,723.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By Stock Award V | shares_owned_after: 11,906.00 | Footnotes: F4
• Holds 188,235 shares of Stock Options (right to buy) at $15.6 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2029-07-23 | Exercise: 2020-07-23 | shares_owned_after: 188,235.00 | Footnotes: F5
• Holds 12,030 shares of Stock Options (right to buy) at $15.94 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2033-05-01 | Exercise: 2024-05-01 | shares_owned_after: 12,030.00 | Footnotes: F5
• Holds 8,850 shares of Stock Options (right to buy) at $16.49 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2034-03-06 | Exercise: 2025-03-06 | shares_owned_after: 8,850.00 | Footnotes: F6
• Holds 20,310 shares of Stock Options (right to buy) at $16.23 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2035-03-03 | Exercise: 2026-03-03 | shares_owned_after: 20,310.00 | Footnotes: F7
• Holds 20,227 shares of Stock Options (right to buy) at $18.28 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2036-03-02 | Exercise: 2027-03-02 | shares_owned_after: 20,227.00 | Footnotes: F8

Footnotes:

• F1: Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
• F2: Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
• F3: Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.
• F4: Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 2, 2029.
• F5: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
• F6: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.
• F7: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.
• F8: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 2, 2027.